AU StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

BCAL DIAGNOSTICS LTD

0.058

+0.0023.57%

Volume:11.07K

Turnover:642

Market Cap:21.35M

PE:-2.91

High:0.058

Open:0.058

Low:0.058

Close:0.056

52wk High:0.155

52wk Low:0.052

Shares:368.07M

Float Shares:202.44M

Volume Ratio:0.09

T/O Rate:0.01%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-0.020

EPS(LYR):-0.020

ROE:-121.67%

ROA:-46.59%

PB:8.55

PE(LYR):-2.88

Loading ...

Overview Company News Filings

Did Stronger Sales and Quality Shuffle Just Shift Becton Dickinson's (BDX) Investment Narrative?

Simply Wall St.

Becton Dickinson Names Gary Sorsher as Chief Quality Officer

MT Newswires Live

Becton, Dickinson's Consistent Mid-Single-Digit Organic Growth is 12-18 Months Away, RBC Says

MT Newswires Live

Becton, Dickinson Completes Enrollment in Trial for Phasix Mesh

MT Newswires Live

Becton, Dickinson's Fiscal Q3 Results Show Progress Amid Major Headwinds, RBC Says

MT Newswires Live

Becton, Dickinson Fiscal Q3 Adjusted Earnings, Revenue Rise; Lifts 2026 Adjusted EPS Guidance

MT Newswires Live

GUIDANCE: (BDX) Becton Dickinson Expects Fiscal 2026 Adjusted EPS Range $12.62 to $12.72,vs. FactSet Est of $12.61

MT Newswires Live

UBS Initiates Coverage on Becton, Dickinson and Company With Buy Rating, $190 Price Target

MT Newswires Live

3 Dividend Aristocrats Still Worth Watching As Rates Stay Higher For Longer

Simply Wall St.

Goldman Sachs Adjusts Price Target on Becton, Dickinson and Company to $152 From $150, Maintains Neutral Rating

MT Newswires Live

Waters Seen Benefiting From BD Turnaround, Pharma Manufacturing Tailwinds, RBC Says

MT Newswires Live

BCAL to Acquire Shares in Genetic Signatures

Evercore ISI Adjusts Price Target on Becton, Dickinson and Company to $180 From $190

MT Newswires Live

BCAL to Acquire Shares in Genetic Signatures

BCAL Diagnostics Ltd - to Buy 10.2% Stake in Genetic Signatures for A$1.39 Mln

THOMSON REUTERS

Bcal Diagnostics Secures A$4.9 Million Under Convertible Note Facility

BCAL Diagnostics - Secures A$4.9 Mln Under Convertible Note Facility

THOMSON REUTERS

BCAL Diagnostics - Expects Remaining FY26 R&D Tax Offset in October 2026

THOMSON REUTERS

Is Vizient’s Nod to BD CentroVena One Quietly Reframing Becton Dickinson’s (BDX) Competitive Moat?

Simply Wall St.

Becton, Dickinson Secures Vizient Recognition for CentroVena One Insertion System

MT Newswires Live

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.etasphere.com/stock/BDX.AU/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"BDX.AU","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"BDX.AU\",,,,,undefined,":{"symbol":"BDX.AU","market":"AU","secType":"STK","nameCN":"BCAL DIAGNOSTICS LTD","latestPrice":0.058,"timestamp":1787292720000,"preClose":0.056,"halted":0,"volume":11072,"delay":0,"changeRate":0.03571428571428575,"nameEN":"BCAL DIAGNOSTICS LTD","floatShares":202437334,"shares":368067640,"eps":-0.01993,"marketStatus":"Market Closed","change":0.002,"latestTime":"08-21 16:12:00 AEST","open":0.058,"high":0.058,"low":0.058,"amount":642,"amplitude":0,"askPrice":0.074,"askSize":43400,"bidPrice":0.054,"bidSize":6350,"shortable":3,"etf":0,"ttmEps":-0.01993,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":0,"beginTime":1787529600000},"marketStatusCode":7,"adr":0,"exchange":"ASX","adjPreClose":0.056,"openAndCloseTimeList":[[1787270400000,1787292000000]],"volumeRatio":0.0858957768144436,"lotSize":1,"tradeCurrency":"AUD","auctionPricing":{"symbol":"BDX.AU","preClose":0.065,"auctionPrice":0.063,"auctionVolume":3076,"auction":3,"marketStatus":"盘后竞价","timestamp":1786341616106}},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"BDX.AU\",,,,,undefined,":{"symbol":"BDX.AU","floatShares":202437334,"roa":"-46.59%","roe":"-121.67%","lyrEps":-0.020136,"volumeRatio":0.0858957768144436,"shares":368067640,"dividePrice":0,"high":0.058,"amplitude":0,"preClose":0.056,"low":0.058,"week52Low":0.052,"pbRate":"8.55","psRate":"8.41","week52High":0.155,"institutionHeld":0,"latestPrice":0.058,"committee":-0.744724,"eps":-0.01993,"divideRate":0,"volume":11072,"delay":0,"ttmEps":-0.01993,"open":0.058,"prevYearClose":0.105,"prevWeekClose":0.056,"prevMonthClose":0.067,"prevQuarterClose":0.075,"fiveDayClose":0.056,"twentyDayClose":0.078,"sixtyDayClose":0.076},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/BDX.AU\",params:#limit:5,,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"BDX.AU\",market:\"AU\",,,undefined,":[],"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BDX.AU\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2660949476","title":"Did Stronger Sales and Quality Shuffle Just Shift Becton Dickinson's (BDX) Investment Narrative?","url":"https://stock-news.laohu8.com/highlight/detail?id=2660949476","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660949476?lang=en_us&edition=fundamental","pubTime":"2026-08-20 05:33","pubTimestamp":1787175181,"startTime":"0","endTime":"0","summary":"Becton, Dickinson and Company recently reported third-quarter fiscal 2026 results showing higher sales of US$4,983,000,000 compared with a year earlier, while net income for both the quarter and year-to-date periods was lower than the prior year.\nAlongside these mixed earnings, BD advanced its tissue regeneration pipeline by fully enrolling the PREVENT trial for Phasix Mesh and reshaped its quality leadership team with the upcoming appointment of Gary Sorsher as chief quality officer and the...","market":"us","thumbnail":"https://images.simplywall.st/asset/company-cover/103678-main-header/1756253637694","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/company-cover/103678-main-header/1756253637694"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/healthcare/nyse-bdx/becton-dickinson/news/did-stronger-sales-and-quality-shuffle-just-shift-becton-dic","rn_cache_url":null,"directOrigin":true},"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/healthcare/nyse-bdx/becton-dickinson/news/did-stronger-sales-and-quality-shuffle-just-shift-becton-dic","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BDX.AU","BDX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660432145","title":"Becton Dickinson Names Gary Sorsher as Chief Quality Officer","url":"https://stock-news.laohu8.com/highlight/detail?id=2660432145","media":"MT Newswires Live","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660432145?lang=en_us&edition=fundamental","pubTime":"2026-08-18 04:42","pubTimestamp":1786999370,"startTime":"0","endTime":"0","summary":"Becton Dickinson  has named Gary Sorsher as chief quality officer, effective Sept. 8, the company said late Monday.Sorsher was most recently chief quality officer at Edwards Lifesciences , the company said.Becton Dickinson also said that Jeffrey Silvestri, global head of quality, will retire in October.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK7067","LU0130103400.USD","LU0289739343.SGD","BK4504","LU0068578508.USD","LU1150488218.USD","EW","LU0289739699.SGD","BK4567","BK4082","LU1854103824.USD","IE00BYQQ9H92.USD","IHI","LU0006061336.USD","LU0289961442.SGD","LU0477156797.USD","LU1489326972.SGD","LU0648000940.SGD","LU1894683348.USD","LU1571399168.USD","IE00BN0W2V16.EUR","AGNG","LU0130518102.USD","LU0878866978.SGD","BDX.AU","LU0162691827.USD","LU1201861165.SGD","IE00BFXG0V08.USD","BK4585","BDX","IE00BN0W2T93.GBP","LU0266013472.USD","IE00BN0W2W23.USD","LU0345774631.USD","LU1854104046.USD","LU0345774391.USD","SG9999001176.SGD","IE00BFXG1179.USD","LU0985489474.SGD","BK4588","LU0058720904.USD","LU0433182093.SGD","LU0823416689.USD","LU1150488135.SGD","SGXZ57979304.SGD","LU0072461881.USD","LU0985320562.USD","BMED","SG9999013999.USD","LU1894683264.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659166809","title":"Becton, Dickinson's Consistent Mid-Single-Digit Organic Growth is 12-18 Months Away, RBC Says","url":"https://stock-news.laohu8.com/highlight/detail?id=2659166809","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659166809?lang=en_us&edition=fundamental","pubTime":"2026-08-13 23:59","pubTimestamp":1786636784,"startTime":"0","endTime":"0","summary":"Becton, Dickinson  will take 12 to 18 months to have consistent mid-single-digit organic growth as headwinds are expected to persist through fiscal 2027, RBC Capital Markets said in a Thursday note.The company is aiming for a long-term profile of mid-single-digit revenue growth and high-single-digit EPS growth with dividends, RBC analysts said. For fiscal 2027, the management is taking a responsible stance, with revenue growth expected in the low-single digits and modest EPS leverage, according to the note.The analysts said the expected headwinds impacting the company are China, where sales are seen falling to about 3% of revenue in fiscal 2027; its vaccine business, which is down about 30% in the current year but seen stabilizing into the next year; and its Alaris infusion system.RBC is positive on the company's diversified portfolio, BD Excellence program productivity, and commercial momentum across its growth platforms.RBC reiterated the company's stock rating at sector-perform and ","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4585","LU1059921491.USD","LU1854103824.USD","LU0289739343.SGD","LU1201861165.SGD","LU0130518102.USD","LU1150488218.USD","BK4588","IHI","LU0006061336.USD","LU0130103400.USD","BK4504","LU0878866978.SGD","BK7067","LU0068578508.USD","LU1571399168.USD","IE00BFXG1179.USD","LU0511384066.AUD","LU1894683348.USD","LU0985320562.USD","BDX.AU","LU0289961442.SGD","LU0433182093.SGD","LU0072461881.USD","LU0985489474.SGD","LU0162691827.USD","BDX","LU0648000940.SGD","LU1894683264.USD","LU1489326972.SGD","LU1150488135.SGD","LU1854104046.USD","BK4082","LU0266013472.USD","LU0477156797.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658974933","title":"Becton, Dickinson Completes Enrollment in Trial for Phasix Mesh","url":"https://stock-news.laohu8.com/highlight/detail?id=2658974933","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658974933?lang=en_us&edition=fundamental","pubTime":"2026-08-12 19:31","pubTimestamp":1786534268,"startTime":"0","endTime":"0","summary":"Becton, Dickinson  said Wednesday it completed enrollment in a trial evaluating Phasix Mesh for preventing incisional hernias.The company said the study enrolled 477 patients across 32 sites in the US and Europe and will evaluate the use of resorbable mesh to prevent incisional hernias.Patients will be followed through the trial's primary endpoint at 24 months, with longer-term follow-up planned for five years, the company said.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LU0433182093.SGD","BDX","LU0648000940.SGD","BK7067","LU0162691827.USD","LU0985489474.SGD","LU0477156797.USD","LU1059921491.USD","BK4082","LU0072461881.USD","LU0985320562.USD","LU1201861165.SGD","LU1854104046.USD","LU0511384066.AUD","LU1894683348.USD","LU0006061336.USD","BK4585","BK4588","IHI","LU0289739343.SGD","BDX.AU","BK4504","LU1489326972.SGD","LU0289961442.SGD","LU0266013472.USD","IE00BFXG1179.USD","LU0130103400.USD","LU1571399168.USD","LU1894683264.USD","LU0068578508.USD","LU1150488135.SGD","LU1150488218.USD","LU0878866978.SGD","LU0130518102.USD","LU1854103824.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657647934","title":"Becton, Dickinson's Fiscal Q3 Results Show Progress Amid Major Headwinds, RBC Says","url":"https://stock-news.laohu8.com/highlight/detail?id=2657647934","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657647934?lang=en_us&edition=fundamental","pubTime":"2026-08-07 23:44","pubTimestamp":1786117445,"startTime":"0","endTime":"0","summary":"Becton, Dickinson's  fiscal Q3 results delivered another beat and raise and showed the company returning to middle single digit topline growth, RBC Capital Markets said in a note emailed Friday.However, the company's \"growth recovery back to consistent middle single digit growth is yet to be proven out,\" even though the beat was a \"positive indicator of improving business performance,\" the note said.Factors like Alaris, China, and vaccine headwinds will likely weigh on the company's 2027 performance, RBC said.The investment firm noted that the company's management raised the 2026 organic growth outlook to the high end of low single digit from just low single digit previously, and also raised the EPS mid-point guidance.For 2027, however, the framework remains low single digit revenue growth due to a 200 basis-point Alaris remediation headwind and China likely decreasing to 3% to 4% of revenue, the note said.RBC kept the company's sector perform rating and lifted its price target to $180","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LU0068578508.USD","BK7067","PRGS","LU0130518102.USD","BK4504","LU0072461881.USD","LU0985489474.SGD","LU1201861165.SGD","LU2065732104.USD","LU1894683264.USD","LU0006061336.USD","LU0289739343.SGD","LU0511384066.AUD","LU0289961442.SGD","LU1854103824.USD","LU1894683348.USD","LU0477156797.USD","IHI","LU1854104046.USD","LU1150488135.SGD","LU1150488218.USD","BK4585","IE00BFXG1179.USD","LU0266013472.USD","LU0130103400.USD","BK4082","LU0878866978.SGD","BK4588","BK4097","BDX.AU","BDX","LU0433182093.SGD","LU1489326972.SGD","LU0985320562.USD","LU0648000940.SGD","LU1059921491.USD","LU0162691827.USD","LU1571399168.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657638444","title":"Becton, Dickinson Fiscal Q3 Adjusted Earnings, Revenue Rise; Lifts 2026 Adjusted EPS Guidance","url":"https://stock-news.laohu8.com/highlight/detail?id=2657638444","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657638444?lang=en_us&edition=fundamental","pubTime":"2026-08-06 19:08","pubTimestamp":1786014492,"startTime":"0","endTime":"0","summary":"Becton, Dickinson  reported fiscal Q3 adjusted earnings from continuing operations Thursday of $3.23 per diluted share, up from $3.08 a year earlier.Analysts polled by FactSet expected $3.14.Revenue for the quarter ended June 30 was $4.98 billion, compared with $4.73 billion a year earlier.Analysts expected $4.89 billion.For fiscal 2026, the company said it now expects adjusted earnings of $12.62 to $12.72 per diluted share, from its prior guidance of $12.52 to $12.72. Analysts are looking for $12.61.The company maintained its low single-digit plus revenue growth outlook.","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LU0068578508.USD","LU1894683348.USD","LU0477156797.USD","BDX.AU","LU1854104046.USD","IE00BFXG1179.USD","LU0130103400.USD","LU0985320562.USD","LU0130518102.USD","LU1059921491.USD","LU0433182093.SGD","LU0006061336.USD","LU0878866978.SGD","LU1854103824.USD","BK4585","BK4504","LU0985489474.SGD","BK4588","BK7067","LU0266013472.USD","LU0289739343.SGD","LU1150488218.USD","LU1894683264.USD","LU0511384066.AUD","LU0289961442.SGD","LU0648000940.SGD","BDX","LU0072461881.USD","LU0162691827.USD","LU1201861165.SGD","LU1489326972.SGD","LU1150488135.SGD","IHI","BK4082","LU1571399168.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657873676","title":"GUIDANCE: (BDX) Becton Dickinson Expects Fiscal 2026 Adjusted EPS Range $12.62 to $12.72,vs. FactSet Est of $12.61","url":"https://stock-news.laohu8.com/highlight/detail?id=2657873676","media":"MT Newswires Live","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657873676?lang=en_us&edition=fundamental","pubTime":"2026-08-06 18:33","pubTimestamp":1786012400,"startTime":"0","endTime":"0","summary":"GUIDANCE: (BDX) Becton Dickinson Expects Fiscal 2026 Adjusted EPS Range $12.62 to $12.72,vs. FactSet Est of $12.61","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BDX","BDX.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2654883600","title":"UBS Initiates Coverage on Becton, Dickinson and Company With Buy Rating, $190 Price Target","url":"https://stock-news.laohu8.com/highlight/detail?id=2654883600","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2654883600?lang=en_us&edition=fundamental","pubTime":"2026-07-28 22:37","pubTimestamp":1785249441,"startTime":"0","endTime":"0","summary":"Becton, Dickinson and Company (BDX) has an average rating of overweight and mean price target of $176.30, according to analysts polled by FactSet.(MT Newswires covers equity, commodity and economic re","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LU1854103824.USD","BDX","BK7067","LU0072461881.USD","LU0648000940.SGD","LU1150488135.SGD","LU0289961442.SGD","LU0878866978.SGD","BK4082","LU1894683348.USD","LU0068578508.USD","LU0511384066.AUD","LU1571399168.USD","BDX.AU","LU0130518102.USD","LU1150488218.USD","LU1059921491.USD","LU0477156797.USD","LU0130103400.USD","LU1489326972.SGD","BK4504","LU1201861165.SGD","LU1894683264.USD","BK4588","LU0985489474.SGD","BK4585","LU0289739343.SGD","LU0266013472.USD","LU1854104046.USD","LU0433182093.SGD","LU0985320562.USD","IE00BFXG1179.USD","LU0006061336.USD","LU0162691827.USD","IHI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651046482","title":"3 Dividend Aristocrats Still Worth Watching As Rates Stay Higher For Longer","url":"https://stock-news.laohu8.com/highlight/detail?id=2651046482","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2651046482?lang=en_us&edition=fundamental","pubTime":"2026-07-15 06:25","pubTimestamp":1784067949,"startTime":"0","endTime":"0","summary":"With Fed Chair Kevin Warsh signaling that interest rates may stay higher for longer, inflation still above the 2% target, and oil prices jumping after renewed tensions in the Strait of Hormuz, many investors are reassessing how reliable their income stocks really are. Dividend Aristocrats, with long records of raising payouts and a focus on financial discipline, can look appealing when volatility and inflation risks rise together. This article walks through 3 stocks from our Dividend...","market":"hk","thumbnail":"https://images.simplywall.st/asset/company-cover/103678-main-header/1756253637694","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/company-cover/103678-main-header/1756253637694"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/healthcare/nyse-bdx/becton-dickinson/news/3-dividend-aristocrats-still-worth-watching-as-rates-stay-hi","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/healthcare/nyse-bdx/becton-dickinson/news/3-dividend-aristocrats-still-worth-watching-as-rates-stay-hi","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["LU0477156797.USD","LU1854104046.USD","LU0289739343.SGD","LU0472753341.HKD","LU0433182093.SGD","LU1150488218.USD","LU1261432733.SGD","BK4585","CLIX","LU1894683348.USD","LU0878866978.SGD","STE","LU0985489474.SGD","LU0057025933.USD","LU0985320562.USD","LU1150488135.SGD","CGDV","LU0511384066.AUD","LU0069063385.USD","CI","LU0124676726.USD","LU0648000940.SGD","IE00B19Z3B42.SGD","LU0689626769.HKD","EQRR","IE00B19Z3581.USD","BDX.AU","LU1892829315.USD","LU0006061336.USD","LU0162691827.USD","LU0266013472.USD","VIG","BK7067","IE00BSNM7G36.USD","LU0068578508.USD","LU0130518102.USD","BDX","LU1571399168.USD","LU0868494617.USD","IHI","BK4588","LU0130103400.USD","LU0289961442.SGD","LU1894683264.USD","LU0289739699.SGD","LU0058720904.USD","LU0072461881.USD","BK4196","LU1489326972.SGD","LU1854103824.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651170093","title":"Goldman Sachs Adjusts Price Target on Becton, Dickinson and Company to $152 From $150, Maintains Neutral Rating","url":"https://stock-news.laohu8.com/highlight/detail?id=2651170093","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2651170093?lang=en_us&edition=fundamental","pubTime":"2026-07-14 19:31","pubTimestamp":1784028710,"startTime":"0","endTime":"0","summary":"Becton, Dickinson and Company (BDX) has an average rating of overweight and mean price target of $172.73, according to analysts polled by FactSet.(MT Newswires covers equity, commodity and economic re","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LU0878866978.SGD","LU1571399168.USD","LU1894683264.USD","BDX","LU0162691827.USD","LU0072461881.USD","LU0648000940.SGD","IHI","LU1489326972.SGD","LU0006061336.USD","LU0477156797.USD","BK4588","LU1894683348.USD","LU1150488135.SGD","BDX.AU","LU1854103824.USD","LU0130103400.USD","LU0433182093.SGD","BK4585","IE00BFXG1179.USD","BK4504","LU1854104046.USD","BK7067","LU1201861165.SGD","LU1059921491.USD","LU0985320562.USD","LU0985489474.SGD","LU0130518102.USD","LU0289961442.SGD","LU0511384066.AUD","LU0068578508.USD","BK4082","LU0266013472.USD","LU1150488218.USD","LU0289739343.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2650292125","title":"Waters Seen Benefiting From BD Turnaround, Pharma Manufacturing Tailwinds, RBC Says","url":"https://stock-news.laohu8.com/highlight/detail?id=2650292125","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2650292125?lang=en_us&edition=fundamental","pubTime":"2026-07-09 20:23","pubTimestamp":1783599816,"startTime":"0","endTime":"0","summary":"Waters  could unlock stronger growth by turning around the recent acquired Becton Dickinson  biosciences and diagnostics businesses while benefiting from resilient demand tied to drug manufacturing, RBC Capital said in a Thursday note.Analysts said the acquired assets were under-managed rather than structurally weak and sees Waters' management applying its turnaround expertise to revive growth.RBC also expects the company to benefit from industry consolidation opportunities and its roughly 15% exposure to pharmaceutical manufacturing, which could gain from US re-shoring trends.RBC initiated coverage with an outperform rating and a $435 price target.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LU0068578508.USD","BK7067","LU0130518102.USD","BK4504","LU0072461881.USD","GB00B4QBRK32.GBP","LU0985489474.SGD","LU1201861165.SGD","WAT","LU1894683264.USD","LU0006061336.USD","LU0289739343.SGD","LU0511384066.AUD","LU0690374961.EUR","LU0289961442.SGD","LU1854103824.USD","LU2404859667.USD","LU1894683348.USD","LU0477156797.USD","LU2413666699.HKD","BD","IHI","LU1854104046.USD","LU1150488135.SGD","LU1150488218.USD","LU2413666426.HKD","BK4585","WAT.AU","IE00BFXG1179.USD","LU0266013472.USD","GB00B4LPDJ14.GBP","BK7118","LU0130103400.USD","BK4082","LU0878866978.SGD","BK4588","BDX.AU","BDX","LU0433182093.SGD","BK4121","LU1489326972.SGD","LU0985320562.USD","LU0648000940.SGD","LU0690374615.EUR","LU1059921491.USD","LU0162691827.USD","LU1721428933.USD","LU0347712357.USD","LU2404859741.USD","LU1571399168.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2649446988","title":"BCAL to Acquire Shares in Genetic Signatures","url":"https://stock-news.laohu8.com/highlight/detail?id=2649446988","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2649446988?lang=en_us&edition=fundamental","pubTime":"2026-07-07 16:38","pubTimestamp":1783413518,"startTime":"0","endTime":"0","summary":"July 2 (Reuters) - BCAL Diagnostics Ltd::*BCAL TO ACQUIRE SHARES IN GENETIC SIGNATURES,GSS*TO BUY 10.2% STAKE IN GENETIC SIGNATURES FOR A$1.39 MILLION*Further company coverage: BDX.AX* ((Reuters.Brief","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260707:nRSDXrYJs:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7067","GSS.AU","BK7501","BDX.AU","BK7048"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2649624217","title":"Evercore ISI Adjusts Price Target on Becton, Dickinson and Company to $180 From $190","url":"https://stock-news.laohu8.com/highlight/detail?id=2649624217","media":"MT Newswires Live","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2649624217?lang=en_us&edition=fundamental","pubTime":"2026-07-06 21:21","pubTimestamp":1783344069,"startTime":"0","endTime":"0","summary":"Becton, Dickinson and Company (BDX) has an average rating of overweight and mean price target of $172.55, according to analysts polled by FactSet.(MT Newswires covers equity, commodity and economic re","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BDX.AU","LU1150488135.SGD","LU1571399168.USD","LU0006061336.USD","LU0130518102.USD","LU0985320562.USD","LU0433182093.SGD","IE00BFXG1179.USD","LU0289961442.SGD","LU1059921491.USD","LU1489326972.SGD","LU0985489474.SGD","LU0068578508.USD","BK7067","LU0130103400.USD","IHI","LU0511384066.AUD","LU1854103824.USD","BK4585","LU0162691827.USD","LU0648000940.SGD","LU1894683264.USD","LU0072461881.USD","LU0266013472.USD","BK4588","LU0878866978.SGD","LU1150488218.USD","BK4082","BDX","BK4504","LU0289739343.SGD","LU1201861165.SGD","LU1854104046.USD","LU0477156797.USD","LU1894683348.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2648578901","title":"BCAL to Acquire Shares in Genetic Signatures","url":"https://stock-news.laohu8.com/highlight/detail?id=2648578901","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2648578901?lang=en_us&edition=fundamental","pubTime":"2026-07-02 09:34","pubTimestamp":1782956083,"startTime":"0","endTime":"0","summary":"BRIEF-BCAL To Acquire Shares In Genetic SignaturesJuly 2 (Reuters)-BCAL Diagnostics LtdBDX.AX:BCAL TO ACQUIRE SHARES IN GENETIC SIGNATURES,GSSTO BUY 10.2% STAKE IN GENETIC SIGNATURES FOR A$1.39 MILLIONFurther company coverage:BDX.AX","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260702:nTUE20NLFQ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7501","BK7067","BK7048","GSS.AU","BDX.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2648852202","title":"BCAL Diagnostics Ltd - to Buy 10.2% Stake in Genetic Signatures for A$1.39 Mln","url":"https://stock-news.laohu8.com/highlight/detail?id=2648852202","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2648852202?lang=en_us&edition=fundamental","pubTime":"2026-07-02 08:04","pubTimestamp":1782950657,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260702:nTUE20NLFQ:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7501","BK7067","BK7048","BDX.AU","GSS.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2647449663","title":"Bcal Diagnostics Secures A$4.9 Million Under Convertible Note Facility","url":"https://stock-news.laohu8.com/highlight/detail?id=2647449663","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2647449663?lang=en_us&edition=fundamental","pubTime":"2026-06-29 09:27","pubTimestamp":1782696449,"startTime":"0","endTime":"0","summary":"BRIEF-Bcal Diagnostics Secures A$4.9 Million Under Convertible Note FacilityJune 29 (Reuters)-BCAL Diagnostics LtdBDX.AX:SECURES A$4.9 MILLION UNDER CONVERTIBLE NOTE FACILITYEXPECTS REMAINING FY26 RD TAX OFFSET IN OCTOBER 2026Further company coverage:BDX.AX","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260629:nFWN42Y123:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BDX.AU","BK7067"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2647334978","title":"BCAL Diagnostics - Secures A$4.9 Mln Under Convertible Note Facility","url":"https://stock-news.laohu8.com/highlight/detail?id=2647334978","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2647334978?lang=en_us&edition=fundamental","pubTime":"2026-06-29 07:57","pubTimestamp":1782691058,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260628:nFWN42Y123:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7067","BDX.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2647234978","title":"BCAL Diagnostics - Expects Remaining FY26 R&D Tax Offset in October 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2647234978","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2647234978?lang=en_us&edition=fundamental","pubTime":"2026-06-29 07:57","pubTimestamp":1782691058,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260628:nFWN42Y123:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BDX.AU","BK7067"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2647766349","title":"Is Vizient’s Nod to BD CentroVena One Quietly Reframing Becton Dickinson’s (BDX) Competitive Moat?","url":"https://stock-news.laohu8.com/highlight/detail?id=2647766349","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2647766349?lang=en_us&edition=fundamental","pubTime":"2026-06-29 06:14","pubTimestamp":1782684892,"startTime":"0","endTime":"0","summary":"Earlier this month, Becton, Dickinson and Company announced that its BD CentroVena One Insertion System received an Innovative Technology contract from Vizient, recognizing the all-in-one central venous catheter insertion system for its potential to simplify central line placement and enhance patient and clinician safety.\nThis endorsement from Vizient’s expert hospital councils highlights CentroVena One’s differentiated workflow and safety advantages, which could influence purchasing...","market":"nz","thumbnail":"https://images.simplywall.st/asset/company-cover/103678-main-header/1756253637694","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/company-cover/103678-main-header/1756253637694"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/healthcare/nyse-bdx/becton-dickinson/news/is-vizients-nod-to-bd-centrovena-one-quietly-reframing-becto","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/healthcare/nyse-bdx/becton-dickinson/news/is-vizients-nod-to-bd-centrovena-one-quietly-reframing-becto","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["LU0985489474.SGD","LU1854104046.USD","LU1894683348.USD","LU1571399168.USD","BDX","LU0162691827.USD","BK4585","LU0130518102.USD","LU1894683264.USD","LU0289739343.SGD","BK7067","LU0648000940.SGD","LU1489326972.SGD","BK4504","LU0985320562.USD","LU0878866978.SGD","LU1201861165.SGD","LU0266013472.USD","BD","BK4082","LU0006061336.USD","LU0072461881.USD","LU0289961442.SGD","LU0068578508.USD","IE00BFXG1179.USD","LU0130103400.USD","LU0511384066.AUD","LU1150488218.USD","LU0433182093.SGD","LU1150488135.SGD","LU1854103824.USD","LU0477156797.USD","BDX.AU","BK4588","LU1059921491.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2645833309","title":"Becton, Dickinson Secures Vizient Recognition for CentroVena One Insertion System","url":"https://stock-news.laohu8.com/highlight/detail?id=2645833309","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2645833309?lang=en_us&edition=fundamental","pubTime":"2026-06-23 19:15","pubTimestamp":1782213326,"startTime":"0","endTime":"0","summary":"Becton, Dickinson  said Tuesday that Vizient granted an Innovative Technology contract to its BD CentroVena One central venous catheter insertion system.The medical technology company said the contract, awarded after an evaluation by hospital experts on Vizient's client-led councils, recognizes products with the potential to enhance healthcare delivery.The integrated device simplifies the procedure by combining the guidewire, needle, syringe, and catheter, resulting in 30% fewer steps and up to a 50% shorter procedure time, the company added.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK7067","LU0072461881.USD","LU0266013472.USD","LU0006061336.USD","LU0162691827.USD","LU1894683264.USD","LU1854104046.USD","IE00BFXG1179.USD","LU0648000940.SGD","LU0511384066.AUD","LU1854103824.USD","BDX","LU0130518102.USD","BK4585","LU0477156797.USD","LU1150488135.SGD","BK4082","LU0433182093.SGD","LU1059921491.USD","LU0130103400.USD","LU0289961442.SGD","BK4588","LU1571399168.USD","LU0878866978.SGD","LU1489326972.SGD","LU1894683348.USD","BDX.AU","LU0289739343.SGD","BK4504","LU0068578508.USD","LU0985320562.USD","LU1150488218.USD","LU1201861165.SGD","LU0985489474.SGD"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":3,"pageCount":1,"totalSize":48,"code":"91000000","status":"200"}]}}